Strides Shasun intimates of successful USFDA inspection of Cuddalore manufacturing facility

Last Updated : Apr 25 2017 | 12:03 AM IST

Receives Zero 483 observations

Strides Shasun announced that its API manufacturing site at Cuddalore was recently inspected by US FDA. The Company has successfully completed this inspection with Zero 483 observations.

Powered by Capital Market - Live News

Connect with us on WhatsApp

Strides Shasun's Cuddalore plant completes USFDA inspection

Alkem Laboratories intimates of successful USFDA Bio-analytical Inspection

Strides Shasun R&D unit gets USFDA inspection closure report

Alembic Pharmaceuticals intimates of successful inspection of its Baroda facility

Marksans Pharma intimates of USFDA inspection of its manufacturing facility at Goa

First Published: Apr 24 2017 | 7:36 PM IST

Explore News

Market LIVE
Market Today
Sai Life Sciences IPO
Parliament Winter Session 2024 LIVE
Latest News LIVE
Stocks To Watch Today
Process to withdraw PF by ATM
Gold-Silver Price Today
IPO News
Business Standard at 50